BSE filing, NSE: RICHIRICH. Summary written from the filing by ALFA Finder's alert engine.
Kisaan Parivar Industries Ltd: key numbers
- Share price
- ₹9.29
- Market cap
- ₹8.18 Cr
- Revenue (annual)
- ₹4.05 Cr
- Net profit (annual)
- ₹0.80 Cr
- P/E (TTM)
- 10.3×Sector 43.1×
- Promoter holding
- 59.25%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kisaan Parivar Industries Ltd
All →Kisaan Parivar Industries Management Change
Kisaan Parivar Industries' statutory auditor M/s MGS Reddy & Co resigned due to pre-occupation. The company must now appoint a new auditor to ensure compliance.
Kisaan Parivar Industries Other Announcement
Kisaan Parivar Industries' statutory auditors have resigned. The company has intimated this change under Regulation 30, signalling a forthcoming auditor appointment.
Kisaan Parivar Industries Q4 FY26 Results: Net Loss of ₹0.2 Cr
Kisaan Parivar Industries Ltd reported revenue from operations of ₹0.5 Cr (-68.8% YoY) and a net loss of ₹0.2 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.2 Cr
Kisaan Parivar Industries Financial Results
Kisaan Parivar Industries reported a total income of ₹4.05 Crore for FY26. The Board approved audited results featuring an unmodified opinion from statutory auditors.
- Value
- ₹4.05 Cr
Kisaan Parivar Industries Other Announcement
Kisaan Parivar Industries submitted a non-applicability certificate for the Annual Secretarial Compliance Report. The company remains exempt due to being below SEBI LODR regulatory thresholds.
Kisaan Parivar Industries Debt & Borrowing
Kisaan Parivar Industries Limited submitted its annual disclosure for FY 2025-26, confirming it does not meet the criteria to be identified as a Large Corporate under SEBI norms. The company reported zero incremental borrowings and no mandatory requirement for debt security issuance for the period.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.